Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery

Affiliations

• ¹ Johns Hopkins University, Baltimore, Maryland.
• ² Massachusetts General Hospital, Boston, Massachusetts.
• ³ University of Alabama Birmingham, Birmingham, Alabama.
• ⁴ Dana-Farber Cancer Institute, Boston, Massachusetts.
• ⁵ Cleveland Clinic, Cleveland, Ohio.
• ⁶ University of California Los Angeles, Los Angeles, California.
• ⁷ University of Minnesota, Minneapolis, Minnesota.
• ⁸ Mayo Clinic, Rochester, Minnesota.
• ⁹ National Cancer Institute, Bethesda, Maryland.
• ¹⁰ Yale University, New Haven, Connecticut.